Partnership in early drug development
February 21, 2012
As expected, the European Commission has granted marketing authorisation for AstraZeneca's thyroid cancer pill Caprelsa
November 20, 2011
The latest set of opinions from the EMA has brought good news for AstraZeneca and Merck KGaA, while the safety of Boehringer Ingelheim's Pradaxa has been backed despite an increasing number of fatal cases of bleeding in patients treated with the anticoagulant.
PharmaTimes 2013 Copyright | RSS Feed Subscriptions Website by DCSL Software